[
  {
    "ts": null,
    "headline": "Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report",
    "summary": "A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion in 2024, with projections pointing to continued growth through 2029. The twelfth edition of Worldwide Market for Point-of-Care Diagnostic Tests, 12th Edition highlights how decentralization of healthcare, rapid innovation, and consumer-driven demand are reshaping how and where diagnostic tests are performed—from traditional clinical settings to homes, workplaces, and remo",
    "url": "https://finnhub.io/api/news?id=8c0bb388e71af4267aabec993ec2d1c6d8d6206d34825ef164bb96b3fa5159b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753810980,
      "headline": "Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report",
      "id": 136120341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion in 2024, with projections pointing to continued growth through 2029. The twelfth edition of Worldwide Market for Point-of-Care Diagnostic Tests, 12th Edition highlights how decentralization of healthcare, rapid innovation, and consumer-driven demand are reshaping how and where diagnostic tests are performed—from traditional clinical settings to homes, workplaces, and remo",
      "url": "https://finnhub.io/api/news?id=8c0bb388e71af4267aabec993ec2d1c6d8d6206d34825ef164bb96b3fa5159b5"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=5dfe13fadfc52c8e45f05959c439f52e72c3d017d36ea36b488ccc040abbdf58",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753806780,
      "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "id": 136134510,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=5dfe13fadfc52c8e45f05959c439f52e72c3d017d36ea36b488ccc040abbdf58"
    }
  },
  {
    "ts": null,
    "headline": "A new infant formula seven years in the making is hitting the $2 billion market",
    "summary": "Nara Organics will compete with other startup brands like Bobbie.",
    "url": "https://finnhub.io/api/news?id=29b9beb26c71275d4b0b51d842e60d36e7d645451d5e5a73edcc3afe93efd82b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753797749,
      "headline": "A new infant formula seven years in the making is hitting the $2 billion market",
      "id": 136119249,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Nara Organics will compete with other startup brands like Bobbie.",
      "url": "https://finnhub.io/api/news?id=29b9beb26c71275d4b0b51d842e60d36e7d645451d5e5a73edcc3afe93efd82b"
    }
  },
  {
    "ts": null,
    "headline": "Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott",
    "summary": "The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leadi",
    "url": "https://finnhub.io/api/news?id=907abd71e0acf14c85f08841aca27b3d4c98ed558bc2e3023b6b30a4cb1eb943",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753778280,
      "headline": "Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott",
      "id": 136117045,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leadi",
      "url": "https://finnhub.io/api/news?id=907abd71e0acf14c85f08841aca27b3d4c98ed558bc2e3023b6b30a4cb1eb943"
    }
  },
  {
    "ts": null,
    "headline": "North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers",
    "summary": "The North America Autoimmune Disease Diagnostics Market is projected to grow from USD 1.96 billion in 2024 to USD 3.5 billion by 2033, at a CAGR of 6.66%. Key growth drivers include rising incidence of autoimmune conditions like rheumatoid arthritis and type 1 diabetes, advancements in diagnostic technologies, and increased healthcare investments. Enhanced diagnostic techniques such as ELISA and next-gen sequencing are improving early detection, with hospitals and clinics expanding sophisticated",
    "url": "https://finnhub.io/api/news?id=e184349c323eaa1227041dd48d800a6db5cea3c58e94a5f94cc637b190910470",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753777860,
      "headline": "North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers",
      "id": 136117046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The North America Autoimmune Disease Diagnostics Market is projected to grow from USD 1.96 billion in 2024 to USD 3.5 billion by 2033, at a CAGR of 6.66%. Key growth drivers include rising incidence of autoimmune conditions like rheumatoid arthritis and type 1 diabetes, advancements in diagnostic technologies, and increased healthcare investments. Enhanced diagnostic techniques such as ELISA and next-gen sequencing are improving early detection, with hospitals and clinics expanding sophisticated",
      "url": "https://finnhub.io/api/news?id=e184349c323eaa1227041dd48d800a6db5cea3c58e94a5f94cc637b190910470"
    }
  },
  {
    "ts": null,
    "headline": "Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche",
    "summary": "The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed",
    "url": "https://finnhub.io/api/news?id=80cce2c4a6b5656f1728f280feb7b727100f47c335d552d98cfacd4b0630d77c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753776120,
      "headline": "Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche",
      "id": 136117047,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Human Papillomavirus (HPV) Testing Market is projected to grow from USD 1.52 billion in 2024 to USD 3.62 billion by 2033, at a 10.11% CAGR from 2025. This growth is fueled by increased cervical cancer awareness, robust screening programs, and advancements in diagnostic technologies. HPV, a significant sexually transmitted infection, plays a critical role in cervical and other cancers, highlighting the importance of early detection through testing. Global initiatives, especially in developed",
      "url": "https://finnhub.io/api/news?id=80cce2c4a6b5656f1728f280feb7b727100f47c335d552d98cfacd4b0630d77c"
    }
  },
  {
    "ts": null,
    "headline": "BME: The Resilient Income Investment Of The Healthcare Industry",
    "summary": "BlackRock Health Sciences Trust offers a resilient 8.63% dividend yield, low expense ratio, and conservative, low-risk positioning. See more on BME ETF here.",
    "url": "https://finnhub.io/api/news?id=78240d01203e7108640de3e61a12e015ad3c84d30c01e10965bf01bcf0b6bbe0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753747321,
      "headline": "BME: The Resilient Income Investment Of The Healthcare Industry",
      "id": 136112843,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1635084121/image_1635084121.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "BlackRock Health Sciences Trust offers a resilient 8.63% dividend yield, low expense ratio, and conservative, low-risk positioning. See more on BME ETF here.",
      "url": "https://finnhub.io/api/news?id=78240d01203e7108640de3e61a12e015ad3c84d30c01e10965bf01bcf0b6bbe0"
    }
  }
]